CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 650456-650636 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/867ebb2be2d466bcb35e5a7319708eaff39c4799","sourcedb":"CORD-19","sourceid":"867ebb2be2d466bcb35e5a7319708eaff39c4799","text":"Among the isolates, the prevailing serotypes were non-PCV13 serotypes 15A (14.5%), 35B (11.8%), 15C (9.3%), 23A (9.0%), 10A, 15B, 11A, and 34, accounting for 74.3% of all isolates.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T190","span":{"begin":0,"end":180},"obj":"Sentence"}],"attributes":[{"subj":"T190","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T21971","span":{"begin":0,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T21971","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#ec93d3","default":true},{"id":"CORD-19-Sentences","color":"#93ecea"}]}]}}